Concepedia

Pharmaceutical composition for treating macular degeneration (WO2012079419)

Shusheng Wang, Khrishen Cunnusamy

Expert Opinion on Therapeutic Patents · 2012 · 58 citations · 23 references

DOIFull text

Open access

Concepts

Abstract

A pharmaceutical composition composed of several traditional Chinese medicines is claimed to treat age-related macular degeneration (AMD). This represents a novel and alternative therapeutic solution for wet AMD, with the potential advantage of treating both the symptoms and the underlying causes of this devastating degenerative retinal disease.

References

23

Ranibizumab for Neovascular Age-Related Macular Degeneration

Philip J. Rosenfeld, David M. Brown, Jeffrey S. Heier et al. · New England Journal of Medicine · 2006 · 5.8K citations · Full text

Prevalence of Age-Related Macular Degeneration in the United States

Archives of Ophthalmology · 2004 · 2.7K citations · Full text

Ranibizumab versus Verteporfin Photodynamic Therapy for Neovascular Age-Related Macular Degeneration: Two-Year Results of the ANCHOR Study

David M. Brown, Mark Michels, Peter K. Kaiser et al. · Ophthalmology · 2008 · 1.3K citations

, , +5

Curcumin protects retinal cells from light-and oxidant stress-induced cell death

Md Nawajes A. Mandal, Jagan M.R. Patlolla, Lixin Zheng et al. · Free Radical Biology and Medicine · 2008 · 216 citations · Full text

, , +8

Anti-amyloid therapy protects against retinal pigmented epithelium damage and vision loss in a model of age-related macular degeneration

Jindong Ding, Lincoln V. Johnson, Rolf Herrmann et al. · Proceedings of the National Academy of Sciences · 2011 · 187 citations · Full text